Skip to main content

Utility of Cardiac Ultrasound Imaging in Oncology, a Case Based Illustration

  • Chapter
  • First Online:
Book cover Cancer and Cardiovascular Disease

Abstract

Cardiac Ultrasound imaging (Echocardiogram) is an integral modality for the investigation of patients undergoing chemotherapy. In this chapter we briefly discuss the evolution and provide case based illustrations to exemplify the use of this modality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Kobayashi T, Nakayama R, Takatani O, Kimura K. Positive chronotropic and inotropic actions of new antitumor agent adriamycin and its cardiotoxicity–its special references to myocardial contractile force and the change of the transmembrane action potential. Jpn Circ J. 1972;36:259–65.

    PubMed  CAS  Google Scholar 

  2. Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 1973;32:302–14.

    Article  CAS  PubMed  Google Scholar 

  3. Rinehart JJ, Lewis RP, Balcerzak SP. Adriamycin cardiotoxicity in man. Ann Intern Med. 1974;81:475–8.

    Article  CAS  PubMed  Google Scholar 

  4. Greco FA, Brereton HD, Rodbard D. Noninvasive monitoring of adriamycin cardiotoxicity by “Sphygmo-Recording” of the pulse wave delay (QKd interval). Cancer Treat Rep. 1976;60:1239–45.

    PubMed  CAS  Google Scholar 

  5. Ramos A, Meyer RA, Korfhagen J, Wong KY, Kaplan S. Echocardiographic evaluation of adriamycin cardiotoxicity in children. Cancer Treat Rep. 1976;60:1281–4.

    PubMed  CAS  Google Scholar 

  6. Alcan KE, Robeson W, Graham MC, Palestro C, Oliver FH, Benua RS. Early detection of anthracycline-induced cardiotoxicity by stress radionuclide cineangiography in conjunction with Fourier amplitude and phase analysis. Clin Nucl Med. 1985;10:160–6.

    Article  CAS  PubMed  Google Scholar 

  7. Lenzhofer R, Dudczak R, Gumhold G, Graninger W, Moser K, Spitzy KH. Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathy. J Cancer Res Clin Oncol. 1983;106:136–42.

    Article  CAS  PubMed  Google Scholar 

  8. McKillop JH, Bristow MR, Goris ML, Billingham ME, Bockemuehl K. Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. Am Heart J. 1983;106:1048–56.

    Article  CAS  PubMed  Google Scholar 

  9. Pauwels EK, Horning SJ, Goris ML. Sequential equilibrium gated radionuclide angiocardiography for the detection of doxorubicin cardiotoxicity. Radiother Oncol. 1983;1:83–7.

    Article  CAS  PubMed  Google Scholar 

  10. Senior R, Soman P, Khattar RS, Lahiri A. Improved endocardial visualization with second harmonic imaging compared with fundamental two-dimensional echocardiographic imaging. Am Heart J. 1999;138:163–8.

    Article  CAS  PubMed  Google Scholar 

  11. Hundley WG, Kizilbash AM, Afridi I, Franco F, Peshock RM, Grayburn PA. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J Am Coll Cardiol. 1998;32:1426–32.

    Article  CAS  PubMed  Google Scholar 

  12. Chuang ML, Hibberd MG, Salton CJ, Beaudin RA, Riley MF, Parker RA, et al. Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging. J Am Coll Cardiol. 2000;35:477–84.

    Article  CAS  PubMed  Google Scholar 

  13. Walker J, Bhullar N, Fallah-Rad N, Lytwyn M, Golian M, Fang T, et al. Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging. J Clin Oncol. 2010;28:3429–36.

    Article  PubMed  Google Scholar 

  14. Telli ML, Hunt SA, Carlson RW, Guardino AE. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. J Clin Oncol. 2007;25:3525–33.

    Article  CAS  PubMed  Google Scholar 

  15. Cardinale D, Colombo A, Lamantia G, Colombo N, Civelli M, De Giacomi G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55:213–20.

    Article  CAS  PubMed  Google Scholar 

  16. Ernande L, Bergerot C, Rietzschel ER, De Buyzere ML, Thibault H, Pignonblanc PG, et al. Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr. 2011;24:1268–75.e1.

    Article  PubMed  Google Scholar 

  17. Hare JL, Brown JK, Leano R, Jenkins C, Woodward N, Marwick TH. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am Heart J. 2009;158:294–301.

    Article  CAS  PubMed  Google Scholar 

  18. Fallah-Rad N, Walker JR, Wassef A, Lytwyn M, Bohonis S, Fang T, et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol. 2011;57:2263–70.

    Article  CAS  PubMed  Google Scholar 

  19. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011;107:1375–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63:2751–68.

    Article  PubMed  Google Scholar 

  21. Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014;27:911–39.

    Article  PubMed  Google Scholar 

  22. Marwick TH. Consistency of myocardial deformation imaging between vendors. Eur J Echocardiogr. 2010;11(5):414–6. https://doi.org/10.1093/ejechocard/jeq006. Epub 17 Feb 2010.

    Article  PubMed  Google Scholar 

  23. Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popović ZB, Marwick TH. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2013;61(1):77–84. https://doi.org/10.1016/j.jacc.2012.09.035. Epub 28 Nov 2012.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jose A. Banchs M.D., F.A.C.C., F.A.S.E. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Banchs, J.A. (2018). Utility of Cardiac Ultrasound Imaging in Oncology, a Case Based Illustration. In: Yusuf, S., Banchs, J. (eds) Cancer and Cardiovascular Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-62088-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-62088-6_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-62086-2

  • Online ISBN: 978-3-319-62088-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics